Your search returned 17 results.

Results
	1.	A regulatory perspective on the role of drug interactions in antiretroviral drug development. [electronic resource] by Struble, Kimberly A Reynolds, Kellie Schoolar Producer: 20091216 In: Current opinion in HIV and AIDS vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients. [electronic resource] by Naeger, Lisa K Struble, Kimberly A Producer: 20070329 In: AIDS (London, England) vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients. [electronic resource] by Naeger, Lisa K Struble, Kimberly A Producer: 20060629 In: AIDS (London, England) vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Reply to Tan et al. [electronic resource] by Kuhar, David T Struble, Kimberly A Henderson, David K Producer: 20150212 In: Infection control and hospital epidemiology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Regulatory issues in developing new HIV protease inhibitors: risks and benefits. [electronic resource] by Struble, Kimberly A Chan-Tack, Kirk M Soon, Guoxing Greg Producer: 20091216 In: Current opinion in HIV and AIDS vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Intracranial hemorrhage and liver-associated deaths associated with tipranavir/ritonavir: review of cases from the FDA's Adverse Event Reporting System. [electronic resource] by Chan-Tack, Kirk M Struble, Kimberly A Birnkrant, Debra B Producer: 20081230 In: AIDS patient care and STDs vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Scientific considerations for pharmacoenhancers in antiretroviral therapy. [electronic resource] by Arya, Vikram Robertson, Sarah M Struble, Kimberly A Murray, Jeffrey S Producer: 20130308 In: Journal of clinical pharmacology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Running a tightrope: regulatory challenges in the development of antiretrovirals. [electronic resource] by Naeger, Lisa K Struble, Kimberly A Murray, Jeffrey S Birnkrant, Debra B Producer: 20100329 In: Antiviral research vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System. [electronic resource] by Chan-Tack, Kirk M Truffa, Melissa M Struble, Kimberly A Birnkrant, Debra B Producer: 20070806 In: AIDS (London, England) vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective. [electronic resource] by Sampson, Mario R Troy, Stephanie B Belew, Yodit Arya, Vikram Struble, Kimberly A Producer: 20210621 In: Current opinion in HIV and AIDS vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint. [electronic resource] by Boyd, Sarita D Sampson, Mario R Viswanathan, Prabha Struble, Kimberly A Arya, Vikram Sherwat, Adam I Producer: 20200604 In: AIDS (London, England) vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Are literature references sufficient for dose recommendations? An FDA case study of efavirenz and rifampin. [electronic resource] by DiGiacinto, Jennifer L Chan-Tack, Kirk M Robertson, Sarah M Reynolds, Kellie S Struble, Kimberly A Producer: 20080528 In: Journal of clinical pharmacology vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	HIV clinical trial design for antiretroviral development: moving forward. [electronic resource] by Chan-Tack, Kirk M Struble, Kimberly A Morgensztejn, Nathalie Murray, Jeffrey S Gulick, Roy Cheng, Ben Weller, Ian Miller, Veronica Producer: 20090220 In: AIDS (London, England) vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. [electronic resource] by Kuhar, David T Henderson, David K Struble, Kimberly A Heneine, Walid Thomas, Vasavi Cheever, Laura W Gomaa, Ahmed Panlilio, Adelisa L Producer: 20140320 In: Infection control and hospital epidemiology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Why did the FDA approve efavirenz 800 mg when co-administered with rifampin? [electronic resource] by Liu, Jiang Chan-Tack, Kirk M Jadhav, Pravin Seo, Shirley Robertson, Sarah M Kraft, Jeffrey Singer, Mary E Struble, Kimberly A Arya, Vikram Producer: 20140814 In: International journal of clinical pharmacology and therapeutics vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008). [electronic resource] by Soon, Guoxing Greg Min, Min Struble, Kimberly A Chan-Tack, Kirk M Hammerstrom, Thomas Qi, Karen Zhou, Susan Bhore, Rafia Murray, Jeffrey S Birnkrant, Debra B Producer: 20121204 In: AIDS patient care and STDs vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. [electronic resource] by Smith, Dawn K Grohskopf, Lisa A Black, Roberta J Auerbach, Judith D Veronese, Fulvia Struble, Kimberly A Cheever, Laura Johnson, Michael Paxton, Lynn A Onorato, Ida M Greenberg, Alan E Producer: 20050207 In: MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports vol. 54 Availability: No items available. Save to lists Add to cart (remove)